MedPath

A blended brain training treatment for overthinking in students

Not Applicable
Recruiting
Conditions
depression
anxiety
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12624000758505
Lead Sponsor
niversity of Otago
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Current student at University of Otago, Christchurch campus or University of Canterbury, Christchurch campus
Aged between 18 and 65 years
Self-reporting high levels of rumination (> 50 on the Ruminative Responses Scale)

Exclusion Criteria

current suicidal ideation
bipolar disorder
psychotic disorder
neurological disease
current severe substance use disorder
unable to communicate in English
inability to engage with an online intervention

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility - recruitment rate and strategy[Numbers of individuals expressing interest, completed online screening for rumination levels, number eligible, number consented Assessed at the conclusion of the recruitment period.];Feasibility - adherence to study protocol[Number of sessions completed over the intervention period, number of people who completed baseline, treatment-end and follow-up research measures Baseline to treatment-end (2 weeks after baseline) to follow-up (6 weeks after baseline)];Feasibility - treatment acceptability and experience. This will be assessed as a composite outcome.[End-of-treatment qualitative interview. this will be a semi-structured, one-on-one, face-to-face interview, by a research assistant. Treatment-end (2 weeks after baseline)]
Secondary Outcome Measures
NameTimeMethod
Objective cognitive function[Screen for Cognitive Impairment in Psychiatry - a brief (10 minutes) cognitive testing battery covering domains of verbal learning and memory, executive function, processing speed, and visuospatial ability. Conducted by a research assistant, who will be trained by a clinical neuropsychologist (KD). Baseline, treatment-end (2 weeks after baseline)];Subjective cognitive function[Cognitive Failures Questionnaire - self-report questionnaire Baseline, treatment-end (2 weeks after baseline)];Rumination[Ruminative Responses Scale - self-report questionnaire Baseline, treatment-end (2 weeks after baseline)];Depression and anxiety. This will be assessed as a composite outcome. [Depression Anxiety and Stress Scale - self-report questionnaire Baseline, treatment-end (2 weeks after baseline)]
© Copyright 2025. All Rights Reserved by MedPath